San Diego, CA, United States of America

Beatrice Diana Darimont

This inventor holds 38 USPTO granted patents and 26 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Muscular Dystrophy Treatments. Top assignee: Avidity Biosciences, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beatrice Diana Darimont. Retrieved from https://idiyas.com/inventor/beatrice-diana-darimont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.6

ph-index = 9

Forward Citations = 249(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Facioscapulohumeral Dystrophy
Myotonic Dystrophy
Nucleic Acid Compositions
Polypeptide Compositions
Anti-Transferrin Receptor Antibodies
Exon Skipping
Muscle Atrophy
Therapeutic Methods
38 patents (USPTO):Explore Patents

Title: The Innovator: Beatrice Diana Darimont, Pioneering Treatments for Muscular Dystrophy

Introduction: Beatrice Diana Darimont, a talented inventor based in San Diego, CA (US), has made significant contributions to the field of biotechnology with a total of 21 patents to her name. Her groundbreaking work at Avidity Biosciences, Inc. is revolutionizing the treatment of muscular dystrophy.

Latest Patents:

Beatrice's latest patents showcase her dedication to advancing therapies for debilitating conditions:

1. Compositions and methods of treating facioscapulohumeral muscular dystrophy - Introducing innovative polynucleic acid molecules, pharmaceutical compositions, and treatment methods for managing facioscapulohumeral muscular dystrophy (FSHD).

2. Compositions and methods of treating muscle atrophy and myotonic dystrophy - Revealing cutting-edge polynucleic acid molecules, pharmaceutical compositions, and treatment techniques for addressing muscle atrophy and myotonic dystrophy.

Career Highlights:

Throughout her illustrious career, Beatrice has demonstrated unwavering commitment to scientific progress and medical innovation. Her relentless pursuit of excellence has led to the development of groundbreaking therapies that have the potential to transform the lives of individuals affected by muscular dystrophy.

Collaborations:

Beatrice has collaborated closely with esteemed colleagues such as Venkata Ramana Doppalapudi and Rob Burke at Avidity Biosciences, Inc. Their collective expertise and shared passion for scientific discovery have propelled them towards groundbreaking advancements in the field of biotechnology.

Conclusion:

Beatrice Diana Darimont's exceptional work ethic, creative ingenuity, and tireless dedication to improving healthcare exemplify the true spirit of innovation. Her remarkable contributions to the treatment of muscular dystrophy underscore the profound impact that inventors like her can have on society. Beatrice's future endeavors are eagerly anticipated as she continues to push the boundaries of scientific exploration in pursuit of life-changing breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…